APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dihydropyridine Calcium Channel Blockers

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dihydropyridine Calcium Channel Blockers Industry Growth and Trends Forecast to 2032

23 December 2025110 pages

Choose your research edition.

Industry ResearchDihydropyridine Calcium Channel Blockers Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Dihydropyridine Calcium Channel Blockers Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Dihydropyridine Calcium Channel Blockers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dihydropyridine Calcium Channel Blockers Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Dihydropyridine Calcium Channel Blockers Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

According to APO Research, the global Dihydropyridine Calcium Channel Blockers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dihydropyridine Calcium Channel Blockers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dihydropyridine Calcium Channel Blockers is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dihydropyridine Calcium Channel Blockers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Dihydropyridine Calcium Channel Blockers market include Teva, Sine Pharma, Shyndec Pharma, Huanghai Pharma, Novartis, Nanjing Easeheal Pharma, Lifeon Pharma, Beijing Hongling Pharma and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dihydropyridine Calcium Channel Blockers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dihydropyridine Calcium Channel Blockers market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dihydropyridine Calcium Channel Blockers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dihydropyridine Calcium Channel Blockers.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Dihydropyridine Calcium Channel Blockers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dihydropyridine Calcium Channel Blockers Market by Company

Teva

Sine Pharma

Shyndec Pharma

Huanghai Pharma

Novartis

Nanjing Easeheal Pharma

Lifeon Pharma

Beijing Hongling Pharma

Bayer

AstraZeneca

Ingenus Pharmaceutical

Hikma Pharmaceuticals

Baxter International

Astellas Pharma

Aguettant

Dihydropyridine Calcium Channel Blockers Segment by Type

Felodipine

Nicardipine

Nifedipine

Iradipine

Other

Dihydropyridine Calcium Channel Blockers Segment by Application

Hospital

Retail Pharmacy

Other

Dihydropyridine Calcium Channel Blockers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dihydropyridine Calcium Channel Blockers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dihydropyridine Calcium Channel Blockers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dihydropyridine Calcium Channel Blockers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Dihydropyridine Calcium Channel Blockers companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Dihydropyridine Calcium Channel Blockers Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Dihydropyridine Calcium Channel Blockers Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Dihydropyridine Calcium Channel Blockers Market Share by Region (2021-2026) Table 4. Global Dihydropyridine Calcium Channel Blockers Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Dihydropyridine Calcium Channel Blockers Market Share by Region (2027-2032) Table 6. Global Dihydropyridine Calcium Channel Blockers Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Dihydropyridine Calcium Channel Blockers Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Dihydropyridine Calcium Channel Blockers Market Size Share by Type (2021-2026) Table 9. Global Dihydropyridine Calcium Channel Blockers Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Dihydropyridine Calcium Channel Blockers Market Size Share Forecasted by Type (2027-2032) Table 11. North America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Dihydropyridine Calcium Channel Blockers Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Dihydropyridine Calcium Channel Blockers Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Dihydropyridine Calcium Channel Blockers Market Size Share by Application (2021-2026) Table 24. Global Dihydropyridine Calcium Channel Blockers Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Dihydropyridine Calcium Channel Blockers Market Size Share Forecasted by Application (2027-2032) Table 26. North America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Dihydropyridine Calcium Channel Blockers Industry Trends Table 37. Dihydropyridine Calcium Channel Blockers Industry Drivers Table 38. Dihydropyridine Calcium Channel Blockers Industry Opportunities and Challenges Table 39. Dihydropyridine Calcium Channel Blockers Industry Restraints Table 40. Global Dihydropyridine Calcium Channel Blockers Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Dihydropyridine Calcium Channel Blockers Revenue Market Share by Company (2021-2026) Table 42. Global Dihydropyridine Calcium Channel Blockers Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Dihydropyridine Calcium Channel Blockers Key Company Headquarters & Area Served Table 44. Global Dihydropyridine Calcium Channel Blockers Company, Product Type & Application Table 45. Global Dihydropyridine Calcium Channel Blockers Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Dihydropyridine Calcium Channel Blockers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Company Information Table 49. Teva Business Overview Table 50. Teva Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Dihydropyridine Calcium Channel Blockers Product Portfolio Table 52. Teva Recent Development Table 53. Sine Pharma Company Information Table 54. Sine Pharma Business Overview Table 55. Sine Pharma Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sine Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio Table 57. Sine Pharma Recent Development Table 58. Shyndec Pharma Company Information Table 59. Shyndec Pharma Business Overview Table 60. Shyndec Pharma Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Shyndec Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio Table 62. Shyndec Pharma Recent Development Table 63. Huanghai Pharma Company Information Table 64. Huanghai Pharma Business Overview Table 65. Huanghai Pharma Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Huanghai Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio Table 67. Huanghai Pharma Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis Dihydropyridine Calcium Channel Blockers Product Portfolio Table 72. Novartis Recent Development Table 73. Nanjing Easeheal Pharma Company Information Table 74. Nanjing Easeheal Pharma Business Overview Table 75. Nanjing Easeheal Pharma Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Nanjing Easeheal Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio Table 77. Nanjing Easeheal Pharma Recent Development Table 78. Lifeon Pharma Company Information Table 79. Lifeon Pharma Business Overview Table 80. Lifeon Pharma Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Lifeon Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio Table 82. Lifeon Pharma Recent Development Table 83. Beijing Hongling Pharma Company Information Table 84. Beijing Hongling Pharma Business Overview Table 85. Beijing Hongling Pharma Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Beijing Hongling Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio Table 87. Beijing Hongling Pharma Recent Development Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Bayer Dihydropyridine Calcium Channel Blockers Product Portfolio Table 92. Bayer Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AstraZeneca Dihydropyridine Calcium Channel Blockers Product Portfolio Table 97. AstraZeneca Recent Development Table 98. Ingenus Pharmaceutical Company Information Table 99. Ingenus Pharmaceutical Business Overview Table 100. Ingenus Pharmaceutical Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Ingenus Pharmaceutical Dihydropyridine Calcium Channel Blockers Product Portfolio Table 102. Ingenus Pharmaceutical Recent Development Table 103. Hikma Pharmaceuticals Company Information Table 104. Hikma Pharmaceuticals Business Overview Table 105. Hikma Pharmaceuticals Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Hikma Pharmaceuticals Dihydropyridine Calcium Channel Blockers Product Portfolio Table 107. Hikma Pharmaceuticals Recent Development Table 108. Baxter International Company Information Table 109. Baxter International Business Overview Table 110. Baxter International Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Baxter International Dihydropyridine Calcium Channel Blockers Product Portfolio Table 112. Baxter International Recent Development Table 113. Astellas Pharma Company Information Table 114. Astellas Pharma Business Overview Table 115. Astellas Pharma Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Astellas Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio Table 117. Astellas Pharma Recent Development Table 118. Aguettant Company Information Table 119. Aguettant Business Overview Table 120. Aguettant Dihydropyridine Calcium Channel Blockers Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Aguettant Dihydropyridine Calcium Channel Blockers Product Portfolio Table 122. Aguettant Recent Development Table 123. North America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2026) Table 126. North America Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Dihydropyridine Calcium Channel Blockers Market Share Forecast by Country (2027-2032) Table 128. Europe Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2026) Table 131. Europe Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Dihydropyridine Calcium Channel Blockers Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2026) Table 136. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Share Forecast by Country (2027-2032) Table 138. Latin America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2026) Table 141. Latin America Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Dihydropyridine Calcium Channel Blockers Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2026) Table 146. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Dihydropyridine Calcium Channel Blockers Product Image Figure 3. Global Dihydropyridine Calcium Channel Blockers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Dihydropyridine Calcium Channel Blockers Market Size (2021-2032) & (US$ Million) Figure 5. Global Dihydropyridine Calcium Channel Blockers Market Share by Region: 2025 VS 2032 Figure 6. Global Dihydropyridine Calcium Channel Blockers Market Share by Region (2021-2032) Figure 7. North America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Felodipine Image Figure 13. Global Felodipine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Nicardipine Image Figure 15. Global Nicardipine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Nifedipine Image Figure 17. Global Nifedipine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Iradipine Image Figure 19. Global Iradipine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Image Figure 21. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Dihydropyridine Calcium Channel Blockers Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Dihydropyridine Calcium Channel Blockers Market Share by Type 2025 VS 2032 Figure 24. North America Dihydropyridine Calcium Channel Blockers Market Size Share by Type (2021-2032) Figure 25. Europe Dihydropyridine Calcium Channel Blockers Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Share by Type (2021-2032) Figure 27. Latin America Dihydropyridine Calcium Channel Blockers Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Dihydropyridine Calcium Channel Blockers Market Size Share by Type (2021-2032) Figure 29. Hospital Image Figure 30. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Retail Pharmacy Image Figure 32. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Dihydropyridine Calcium Channel Blockers Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Dihydropyridine Calcium Channel Blockers Market Share by Application 2025 VS 2032 Figure 37. North America Dihydropyridine Calcium Channel Blockers Market Size Share by Application (2021-2032) Figure 38. Europe Dihydropyridine Calcium Channel Blockers Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Share by Application (2021-2032) Figure 40. Latin America Dihydropyridine Calcium Channel Blockers Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Dihydropyridine Calcium Channel Blockers Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Dihydropyridine Calcium Channel Blockers Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Dihydropyridine Calcium Channel Blockers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Dihydropyridine Calcium Channel Blockers Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2032) Figure 47. Europe Dihydropyridine Calcium Channel Blockers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dihydropyridine Calcium Channel Blockers Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2032) Figure 50. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2032) Figure 53. Latin America Dihydropyridine Calcium Channel Blockers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Dihydropyridine Calcium Channel Blockers Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2032) Figure 56. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Felodipine
  • Nicardipine
  • Nifedipine
  • Iradipine
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Teva
  • Sine Pharma
  • Shyndec Pharma
  • Huanghai Pharma
  • Novartis
  • Nanjing Easeheal Pharma
  • Lifeon Pharma
  • Beijing Hongling Pharma
  • Bayer
  • AstraZeneca
  • Ingenus Pharmaceutical
  • Hikma Pharmaceuticals
  • Baxter International
  • Astellas Pharma
  • Aguettant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Dihydropyridine Calcium Channel Blockers Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Dihydropyridine Calcium Channel Blockers Market Size by Region (2021-2032)
  5. 1.4.1 Global Dihydropyridine Calcium Channel Blockers Market Size by Region (2021-2026)
  6. 1.4.2 Global Dihydropyridine Calcium Channel Blockers Market Size by Region (2027-2032)
  7. 1.5 Key Regions Dihydropyridine Calcium Channel Blockers Market Size (2021-2032)
  8. 1.5.1 North America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (2021-2032)
2 Dihydropyridine Calcium Channel Blockers Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Felodipine
  3. 2.1.2 Nicardipine
  4. 2.1.3 Nifedipine
  5. 2.1.4 Iradipine
  6. 2.1.5 Other
  7. 2.2 Global Dihydropyridine Calcium Channel Blockers Market Size by Type
  8. 2.2.1 Global Dihydropyridine Calcium Channel Blockers Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Dihydropyridine Calcium Channel Blockers Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Dihydropyridine Calcium Channel Blockers Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Dihydropyridine Calcium Channel Blockers Market Size by Regions
  12. 2.3.1 North America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Type (2021-2026)
3 Dihydropyridine Calcium Channel Blockers Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Dihydropyridine Calcium Channel Blockers Market Size by Application
  6. 3.2.1 Global Dihydropyridine Calcium Channel Blockers Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Dihydropyridine Calcium Channel Blockers Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Dihydropyridine Calcium Channel Blockers Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Dihydropyridine Calcium Channel Blockers Market Size by Regions
  10. 3.3.1 North America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Dihydropyridine Calcium Channel Blockers Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Dihydropyridine Calcium Channel Blockers Industry Trends
  2. 4.2 Dihydropyridine Calcium Channel Blockers Industry Drivers
  3. 4.3 Dihydropyridine Calcium Channel Blockers Industry Opportunities and Challenges
  4. 4.4 Dihydropyridine Calcium Channel Blockers Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Dihydropyridine Calcium Channel Blockers Revenue (2021-2026)
  2. 5.2 Global Dihydropyridine Calcium Channel Blockers Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Dihydropyridine Calcium Channel Blockers Key Company Headquarters & Area Served
  4. 5.4 Global Dihydropyridine Calcium Channel Blockers Company, Product Type & Application
  5. 5.5 Global Dihydropyridine Calcium Channel Blockers Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Dihydropyridine Calcium Channel Blockers Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Dihydropyridine Calcium Channel Blockers Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Dihydropyridine Calcium Channel Blockers Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Dihydropyridine Calcium Channel Blockers Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sine Pharma
  8. 6.2.1 Sine Pharma Company Information
  9. 6.2.2 Sine Pharma Business Overview
  10. 6.2.3 Sine Pharma Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sine Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio
  12. 6.2.5 Sine Pharma Recent Developments
  13. 6.3 Shyndec Pharma
  14. 6.3.1 Shyndec Pharma Company Information
  15. 6.3.2 Shyndec Pharma Business Overview
  16. 6.3.3 Shyndec Pharma Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Shyndec Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio
  18. 6.3.5 Shyndec Pharma Recent Developments
  19. 6.4 Huanghai Pharma
  20. 6.4.1 Huanghai Pharma Company Information
  21. 6.4.2 Huanghai Pharma Business Overview
  22. 6.4.3 Huanghai Pharma Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Huanghai Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio
  24. 6.4.5 Huanghai Pharma Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Dihydropyridine Calcium Channel Blockers Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Nanjing Easeheal Pharma
  32. 6.6.1 Nanjing Easeheal Pharma Company Information
  33. 6.6.2 Nanjing Easeheal Pharma Business Overview
  34. 6.6.3 Nanjing Easeheal Pharma Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Nanjing Easeheal Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio
  36. 6.6.5 Nanjing Easeheal Pharma Recent Developments
  37. 6.7 Lifeon Pharma
  38. 6.7.1 Lifeon Pharma Company Information
  39. 6.7.2 Lifeon Pharma Business Overview
  40. 6.7.3 Lifeon Pharma Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Lifeon Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio
  42. 6.7.5 Lifeon Pharma Recent Developments
  43. 6.8 Beijing Hongling Pharma
  44. 6.8.1 Beijing Hongling Pharma Company Information
  45. 6.8.2 Beijing Hongling Pharma Business Overview
  46. 6.8.3 Beijing Hongling Pharma Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Beijing Hongling Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio
  48. 6.8.5 Beijing Hongling Pharma Recent Developments
  49. 6.9 Bayer
  50. 6.9.1 Bayer Company Information
  51. 6.9.2 Bayer Business Overview
  52. 6.9.3 Bayer Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Bayer Dihydropyridine Calcium Channel Blockers Product Portfolio
  54. 6.9.5 Bayer Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca Dihydropyridine Calcium Channel Blockers Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 Ingenus Pharmaceutical
  62. 6.11.1 Ingenus Pharmaceutical Company Information
  63. 6.11.2 Ingenus Pharmaceutical Business Overview
  64. 6.11.3 Ingenus Pharmaceutical Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Ingenus Pharmaceutical Dihydropyridine Calcium Channel Blockers Product Portfolio
  66. 6.11.5 Ingenus Pharmaceutical Recent Developments
  67. 6.12 Hikma Pharmaceuticals
  68. 6.12.1 Hikma Pharmaceuticals Company Information
  69. 6.12.2 Hikma Pharmaceuticals Business Overview
  70. 6.12.3 Hikma Pharmaceuticals Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Hikma Pharmaceuticals Dihydropyridine Calcium Channel Blockers Product Portfolio
  72. 6.12.5 Hikma Pharmaceuticals Recent Developments
  73. 6.13 Baxter International
  74. 6.13.1 Baxter International Company Information
  75. 6.13.2 Baxter International Business Overview
  76. 6.13.3 Baxter International Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Baxter International Dihydropyridine Calcium Channel Blockers Product Portfolio
  78. 6.13.5 Baxter International Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Astellas Pharma Dihydropyridine Calcium Channel Blockers Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 Aguettant
  86. 6.15.1 Aguettant Company Information
  87. 6.15.2 Aguettant Business Overview
  88. 6.15.3 Aguettant Dihydropyridine Calcium Channel Blockers Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Aguettant Dihydropyridine Calcium Channel Blockers Product Portfolio
  90. 6.15.5 Aguettant Recent Developments
7 North America
  1. 7.1 North America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026)
  3. 7.3 North America Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026)
  3. 8.3 Europe Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026)
  3. 10.3 South America Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Dihydropyridine Calcium Channel Blockers Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst